• Home
  • Mutual Funds
  • ITI Pharma and Healthcare Fund Growth

ITI Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

ITI Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

₹238 Cr

Lock In Period

N/A

Expense Ratio

2.38

Exit Load

If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.

Benchmark

NIFTY Healthcare Total Return Index

Summary

ITI Pharma and Healthcare Fund Growth NAV is ₹16.8192 as of 22 Jun, 2026. ITI Pharma and Healthcare Fund Growth has delivered 66.52% returns since its launch. The minimum SIP investment amount in ITI Pharma and Healthcare Fund Growth is ₹500. The AUM of ITI Pharma and Healthcare Fund Growth is ₹238 Cr. The expense ratio of the fund is 2.38%, and its benchmark is NIFTY Healthcare Total Return Index. The current exit load of the fund is If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.. In the last 1M months, ITI Pharma and Healthcare Fund Growth has delivered -0.24% returns.

ITI Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-0.240.2413.06
6M6.891.77125.97
1Y4.094.54202.92
3Y18.5313.01342.40

Portfolio Analysis

  • Equity: 98.00%
  • Debt: 2.00%
  • Others
As on: 2026-05-31
View allocation % by

1. Sun Pharmaceutical Industries Limited14.25%
2. Divi's Laboratories Limited8.43%
3. Laurus Labs Limited5.06%
4. Torrent Pharmaceuticals Limited4.90%
5. Aurobindo Pharma Limited4.28%
6. Dr. Reddy's Laboratories Limited3.98%
7. Lupin Limited3.53%
8. Cipla Limited3.42%
9. Neuland Laboratories Limited3.00%
10. Alkem Laboratories Limited2.88%
11. Cohance Lifesciences Limited2.65%
12. Abbott India Limited2.03%
13. Mankind Pharma Limited1.95%
14. Sai Life Sciences Limited1.63%
15. IPCA Laboratories Limited1.44%
16. Biocon Limited1.26%
17. Piramal Pharma Limited1.24%
18. Glenmark Pharmaceuticals Limited1.23%
19. Shilpa Medicare Limited1.04%
20. Supriya Lifescience Limited1.03%
21. GlaxoSmithKline Pharmaceuticals Limited0.86%
22. Zydus Lifesciences Limited0.76%
23. Caplin Point Laboratories Limited0.48%
24. Syngene International Limited0.41%

1. Apollo Hospitals Enterprise Limited6.20%
2. Max Healthcare Institute Limited4.90%
3. Fortis Healthcare Limited3.02%
4. Aster DM Healthcare Limited1.79%
5. Healthcare Global Enterprises Limited1.17%
6. Rainbow Childrens Medicare Limited1.05%
7. Park Medi World Limited1.02%

1. Shaily Engineering Plastics Limited1.47%

1. Linde India Limited1.30%

1. SBI Life Insurance Company Limited1.22%

1. Jubilant Ingrevia Limited1.12%

About Fund ITI Pharma and Healthcare Fund Growth

ITI Pharma and Healthcare Fund Growth managed by ITI Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹238 Crore. The fund benchmarks its performance against the NIFTY Healthcare Total Return Index while maintaining an expense ratio of 2.38. Under the expert guidance of Animesh Singh ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Animesh Singh

Mr. Animesh Singh holds Post Graduate Diploma in Management, Bachelor of Honours -(Economics) CFA - USA Certification. Prior to joining the ITI AMC, he was associated with Julius Baer wealth Advisor, Centrum Wealth, Nippon Life India Asset Management Ltd, Reliance Portfolio Management Services, KSBL and SSKI Securities.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
ICICI Prudential Housing Opportunities Fund Growth12644.52 CR2
Quant Business Cycle Fund Growth01017.72 CR2.26
ITI Pharma and Healthcare Fund Growth0237.99 CR2.38
HDFC Defence Fund Growth59724.27 CR1.75
Nippon India Taiwan Equity Fund Growth31256.27 CR2.15
Fund Name1Y3Y
This FundICICI Prudential Housing Opportunities Fund Growth2.705951.431
This FundQuant Business Cycle Fund Growth4.059664.9327
This FundITI Pharma and Healthcare Fund Growth4.089966.5243
This FundHDFC Defence Fund Growth14.9064189.4226
This FundNippon India Taiwan Equity Fund Growth198.7903324.3981

ITI Pharma and Healthcare Fund Growth FAQs

ITI Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of ITI Pharma and Healthcare Fund Growth is 2.38. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

ITI Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : -0.24%
  • 6 Months : 6.89%
  • 1 Year : 4.09%
  • 3 Years : 18.53%
Returns of ITI Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 16.8192 as on Jun 19,2026. Since inception, the return has been 66.52%.

You can invest in ITI Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of ITI Pharma and Healthcare Fund Growth is ₹238 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in ITI Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.